Literature DB >> 17549666

Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.

D Stav1, I Bar, J Sandbank.   

Abstract

We used oligonucleotide microarrays with probe sets to 22,283 genes to analyze the gene expression profile of lung adenocarcinoma. Cancerous and noncancerous tissue samples were obtained from 23 patients with stage I or II lung cancer; 18 tissue pairs and 5 cancerous tissues. A list of 2065 genes that differentiate between cancerous and noncancerous tissues was generated using Winsorized paired t-tests. We analyzed CDK5RAP3 and CCNB2, which are involved in cell cycle progression, and RAGE. The first 2 of these 3 genes proved to be overexpressed in tumor tissue, whereas the RAGE gene was suppressed in tumor tissue. When CDK5RAP3 and CCNB2 were examined in individual patients we found that in cases where one of these genes was only slightly overexpressed the other was highly overexpressed. The combined expression of the 2 cell cycle genes was found to be statistically significant for differentiating between cancerous and noncancerous tissues. Inclusion of the data for the RAGE gene made the differentiation more powerful. The gene expression ratio gave a clear result: when CDK5RAP3 was expressed more than RAGE, the tissue was carcinomatous, and vice versa. We therefore conclude that these 3 genes may be used as a very reliable biomarker of lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549666     DOI: 10.1177/172460080702200204

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  32 in total

1.  Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.

Authors:  Abdelfattah El Ouaamari; Jian-Ying Zhou; Chong Wee Liew; Jun Shirakawa; Ercument Dirice; Nicholas Gedeon; Sevim Kahraman; Dario F De Jesus; Shweta Bhatt; Jong-Seo Kim; Therese Rw Clauss; David G Camp; Richard D Smith; Wei-Jun Qian; Rohit N Kulkarni
Journal:  J Proteome Res       Date:  2015-07-30       Impact factor: 4.466

2.  LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro.

Authors:  J Jacob Wamsley; Natalia Issaeva; Hanbing An; Xinyuan Lu; Lawrence A Donehower; Wendell G Yarbrough
Journal:  Cell Cycle       Date:  2016-12-27       Impact factor: 4.534

Review 3.  All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

Authors:  Elizabeth A Oczypok; Timothy N Perkins; Tim D Oury
Journal:  Paediatr Respir Rev       Date:  2017-03-18       Impact factor: 2.726

4.  Moesin is a biomarker for the assessment of genotoxic carcinogens in mouse lymphoma.

Authors:  Yoen Jung Lee; In-Kwon Choi; Yhun Yhong Sheen; Sue Nie Park; Ho Jeong Kwon
Journal:  Mol Cells       Date:  2012-01-26       Impact factor: 5.034

5.  A functional variant of IC53 correlates with the late onset of colorectal cancer.

Authors:  Jingzhou Chen; Yi Shi; Ziyu Li; Hui Yu; Yu Han; Xiaojian Wang; Kai Sun; Tao Yang; Kejia Lou; Yan Song; Yinhui Zhang; Yisong Zhen; Guiguo Zhang; Ying Hu; Jiafu Ji; Rutai Hui
Journal:  Mol Med       Date:  2011-03-02       Impact factor: 6.354

6.  Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors.

Authors:  Yongjun Li; Xiaofen Ye; Jinfeng Liu; Jiping Zha; Lin Pei
Journal:  Neoplasia       Date:  2011-01       Impact factor: 5.715

Review 7.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

8.  Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer.

Authors:  Shinogu Takashima; Hajime Saito; Naoko Takahashi; Kazuhiro Imai; Satoshi Kudo; Maiko Atari; Yoshitaro Saito; Satoru Motoyama; Yoshihiro Minamiya
Journal:  Tumour Biol       Date:  2013-12-28

9.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

10.  The receptor RAGE: Bridging inflammation and cancer.

Authors:  Astrid Riehl; Julia Németh; Peter Angel; Jochen Hess
Journal:  Cell Commun Signal       Date:  2009-05-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.